More articles from 1.5 Diffuse Parenchymal Lung Disease

Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Peter George, Tristan Huie, Jeff Swigris, Kern Buckner, Kevin Brown, Brett Fenster

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4889; DOI: 10.1183/13993003.congress-2016.PA4889
Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
Yutaka Tsuchiya, David Lynch, Takeshi Johkoh, Thomas Colby, Junya Fukuoka, Ryoko Egashira, Hiromitsu Sumikawa, Takenori Okada, Jeffrey Swigris, Joshua Solomon

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4887; DOI: 10.1183/13993003.congress-2016.PA4887
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Riccardo Messina, Alida Benfante, Daniela Castiglia, Claudia I. Gruttad'Auria, Nicola Scichilone

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4888; DOI: 10.1183/13993003.congress-2016.PA4888
Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Martina Kolbeková, Martina Šterclová, Magdalena Smetáková, Peter Paluch, Jan Anton, Jelena Skibová, Martina Vašáková

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4884; DOI: 10.1183/13993003.congress-2016.PA4884
Rituximab in severe, progressive interstitial lung disease
Maria Kokosi, Gregory J. Keir, Tamera J. Corte, Lauren Troy, Peter Saunders, Felix Chua, Toby M. Maher, Elisabetta A. Renzoni, Athol U. Wells

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4886; DOI: 10.1183/13993003.congress-2016.PA4886
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Keita Sakamoto, Shinyu Izumi, Masao Hashimoto, Konomi Kobayashi, Ayako Shiozawa, Eriko Suzuki, Shota Yamamoto, Tomoyuki Suzuki, Satoru Ishi, Eriko Morino, Manabu Suzuki, Jin Takasaki, Go Naka, Hiroyuki Yamashita, Motoyasu Iikura, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4881; DOI: 10.1183/13993003.congress-2016.PA4881
Efficacy of functionalized-imatinib loaded gold nanoparticles on lung fibroblastoid cells from systemic sclerosis patients
Emanuela Cova, Simona Inghilleri, Davide Piloni, Veronica Codullo, Laura Pandolfi, Miriam Colombo, Monica Morosini, Valentina Barzon, Sara Magni, Davide Prosperi, Carlomaurizio Montecucco, Federica Meloni

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4873; DOI: 10.1183/13993003.congress-2016.PA4873
Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?
Hanna Nurmi, Minna Purokivi, Miia Kärkkäinen, Hannu-Pekka Kettunen, Tuomas Selander, Riitta Kaarteenaho

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4885; DOI: 10.1183/13993003.congress-2016.PA4885
Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis
Ourania Koltsida, Evgenia Synolaki, Athanasios Stavropoulos, Pasxalis Sideras, Nikolaos Koulouris, Dimitrios Boumpas, Grigorios Stratakos

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4875; DOI: 10.1183/13993003.congress-2016.PA4875
Survival in CVD-ILD at Ege University Hospital
Nesrin Mogulkoc, Imren Nesil, Aysu Sinem Koc, Zehra Erdemir, Selen Bayraktaroglu, Yasemin Kabasakal, Canan Gunduz, Pervin Korkmaz Ekren, Feza Bacakoglu

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4880; DOI: 10.1183/13993003.congress-2016.PA4880

Main menu

User menu

Search

More articles from 1.5 Diffuse Parenchymal Lung Disease

Pages